TrialJournal of neuro-oncology2023

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.

Kathryn R Tringale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.